| 2024-05-24 | Lineage Cell Therapeutics, Inc. LCTX | President and CEO | 10,000 0.0054% | $1.05 | $10,500 | -9.76% | ||
| 2022-03-31 | Lineage Cell Therapeutics, Inc. LCTX | President and CEO | 6,400 0.0037% | $1.53 | $9,792 | -11.04% | ||
| 2022-03-25 | Lineage Cell Therapeutics, Inc. LCTX | President and CEO | 5,250 0.0029% | $1.38 | $7,245 | -7.43% | ||
| 2021-06-28 | Sale | Lineage Cell Therapeutics, Inc. LCTX | President and CEO | 450,000 0.2743% | $2.87 | $1.29M | -28.72% | |
| 2019-08-13 | Lineage Cell Therapeutics, Inc. LCTX | President and CEO | 10,000 0.0066% | $1.01 | $10,100 | -4.35% | ||
| 2012-03-14 | Savara Inc. SVRA | CEO and Director | 20,500 0.043% | $0.59 | $12,103 | +5.72% | ||
| 2012-03-13 | Savara Inc. SVRA | CEO and Director | 14,000 0.0294% | $0.58 | $8,144 | +7.24% | ||
| 2011-06-02 | Sale | Savara Inc. SVRA | Chief Executive Officer | 5,000 0.019% | $2.44 | $12,200 | -71.31% | |
| 2010-05-27 | Savara Inc. SVRA | Chief Executive Officer | 5,000 0.0425% | $1.89 | $9,450 | +8.29% |